Go beyond traditional employer benefits surveys to understand how employers are balancing cost, employee satisfaction, and administrative burden — and how misaligned incentives between employers and partners are limiting innovation.

• Use these slides to explore the market landscape, including current cost pressures and the top five priorities holding employers’ attention right now.
• Learn about the innovations in virtual and digital healthcare offerings, including health plan virtual-first products and why health plans are investing in the digital front door.
• As behavioral health needs have increased, employer organizations have sought to meet employees’ needs utilizing new tactics.

Employers’ drug spend is rising rapidly with the influx of innovative new drugs hitting the market. While these new pharmaceuticals present opportunities to reshape care, it’s incumbent on employers to strategically keep costs in check.

• As the number of available high-cost drugs continues to increase, we must understand the five major trends that will have an immediate impact on today’s pharmaceutical market.
• With the rise in popularity of weight loss drugs, here are the 5 biggest weight management drug questions (and our answers) stakeholders are asking.
• Payers may be tempted to increase drug copays in order to mitigate higher drug spend. However, we tackle the myth that larger drug copays lower cost of care.

Value-based care is an industry-wide strategy to improve population health and reduce the total cost of care. Get Advisory Board’s cross-industry take on the role employers can play in advancing VBC.

• Go back to basics to understand what VBC is and why the industry is pursuing it.
• See which healthcare stakeholders have the motivation and influence to shape the future of value-based care and learn about the different partnership models in commercial risk.
  
• Take a glimpse into the future to see how employer-driven navigation can enable value-based cancer care.